# Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors

> **NCT03381014** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Chemotherapy Effect

## Interventions

- **DRUG:** Chemotherapy, Cancer, Anthracyclines

## Key facts

- **NCT ID:** NCT03381014
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03381014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03381014, "Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03381014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*